These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2698365)

  • 1. [Insulin pharmacokinetics in insulin-dependent diabetics. Mathematical models].
    Beuscart R; Fontaine P; D'Herbomez-Boidein M
    Diabete Metab; 1989; 15(5):233-41. PubMed ID: 2698365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
    Asakawa N; Saito Y; Yamasaki Y; Kawamori R; Shichiri M
    Diabetes Res; 1987 Aug; 5(4):193-8. PubMed ID: 3311559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin.
    Wilinska ME; Chassin LJ; Schaller HC; Schaupp L; Pieber TR; Hovorka R
    IEEE Trans Biomed Eng; 2005 Jan; 52(1):3-12. PubMed ID: 15651559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo kinetics of 123 iodine-labelled insulin in skeletal muscle of patients with type 2 diabetes. Effect of metformin.
    Valensi P; Behar A; Cohen-Boulakia F; Valensi J; Wiernsperger N; Attali JR
    Diabetes Metab; 2002 Apr; 28(2):95-103. PubMed ID: 11976561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus].
    Hilsted JC; Madsbad S; Rasmussen MH; Hvidberg A; Krarup T; Ipsen H; Hansen B; Pedersen M; Djurup R; Oxenbøll B
    Ugeskr Laeger; 1996 Jun; 158(24):3451-5. PubMed ID: 8650814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
    Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
    Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose dynamics in Type I diabetes: insights from the classic and linear minimal models.
    Fernandez M; Villasana M; Streja D
    Comput Biol Med; 2007 May; 37(5):611-27. PubMed ID: 16867301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No sign of amyloidosis in pump-treated diabetics.
    Regal H; Koivisto VA; Maury CP; Irsigler K
    Diabetes Res; 1988 Aug; 8(4):195-9. PubMed ID: 3069282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I diabetes and insulin therapy.
    Hirsch IB; Farkas-Hirsch R
    Nurs Clin North Am; 1993 Mar; 28(1):9-23. PubMed ID: 8451220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.